News
LAB+ finances 4 Uruguayan scientific start-ups
LAB+ presented this Thursday the closing of its first round of capitalization and the first four start-ups that will be financed with this fund. Each will receive US$ 750,000 for a two-year term. The objective of LAB+ is to support scientists with disruptive ideas in medicine, biology and technology, aimed at improving the welfare of humans,...
IP Montevideo signs first agreement as partner of a biotech start-up
For the first time, the Institut Pasteur de Montevideo became a partner of a biotech start-up -Xeptiva Therapeutics-, a new business model that the institute has been promoting through its Lab+ initiative. The agreement – which is a historic milestone for both parties – was signed on Thursday, December 21, between representatives of the institute...
Innovation in life sciences: focus of the second edition of the Uruguay Innovation Forum at the IP Montevideo
The Institut Pasteur de Montevideo hosted the second edition of the Uruguay Innovation Forum, a national initiative that brings together several institutions that seek to disseminate innovation activities. This second edition was entitled “Disruptive Innovation in Life Sciences” and offered different talks that presented the situation of...
IN THE MEDIA
Local
Forbes Uruguay – Interview with Carlos Batthyány about LAB+ and the Institut Pasteur de Montevideo
Búsqueda – International call for startups, interview with Carlos Batthyány and Paul Elberse
En Perspectiva – Agustín Correa and Matías Machado, from Scaffold Biotech: Uruguayan company works with protein engineering to reach a ‘new frontier in vaccination’.
Modo País (Channel 5) – Guska, created by Pilar Moreno and Gonzalo Moratorio.
En Perspectiva – Felipe Trajtenberg, from LoCBio: reprogramming bacteria to treat colorectal cancer.
La Diaria – What do the first four start-ups of the LAB+ seek to develop?
Telemundo (Channel 12) – Scaffold Biotech: more efficient vaccines for animals.
En Perspectiva – Director of the Institut Pasteur de Montevideo talks about the LAB+ iniciative and Gonzalo Moratorio explains the science behind the start-up Guska.
Subrayado (Channel 10) – LAB+ closed its first financing cycle.
Radio Carve – Director of the Institut Pasteur de Montevideo talks about LAB+.
La Diaria – Conversations with the first four biotech start-ups funded by LAB+.
El País (Business) – Institut Pasteur de Montevideo presented its first four start-ups.
Uruguay XXI – Institut Pasteur de Montevideo presented its first four start-ups.
Telenoche (Channel 4) – Juan Pablo Tosar talks about the start-up B4-RNA.
Ambito – The Institut Pasteur will invest US$25M in Uruguayan start-ups.
El Observador – Four start-ups from the Institut Pasteur de Montevideo obtained financing for US$ 5 million: which are they?
Telenoche (Channel 4) – Institut Pasteur de Montevideo presented its LAB+ Company Builder initiative.
Montevideo Portal – The Institut Pasteur de Montevideo presents a program to support scientific-technological companies.
International
Tekios – LAB+ international call for scientific projects and start-ups
SwissInfo – LAB+ international call for scientific projects and start-ups
Latin American Post – LAB+ pioneers a new era of scientific start-ups in Uruguay and beyond.
Infobae – Closing of first round of financing for LAB+.
EFE – The Institut Pasteur de Montevideo presents LAB+, with four start-ups.
Investing – The Institut Pasteur de Montevideo launches the LAB+ iniciative.
ABC (Paraguay) – With four start-ups, the Institut Pasteur de Montevideo launches the LAB+.
Bloomberg – New Venture Capital Fund Eyes Latin American Science Start-ups.
Bloomberg online – New venture capital fund sets its sights on Latin American scientific start-ups.
Perfil – A new venture capital fund targets Latin American science.
iProUP – Support for startups: Ficus Capital, biotech fund, looks for unicorns in Latin America.
Yahoo Finances – Biotech fund seeks unicorns in LatAm.